Timing of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cells

Journal of Virology

Volumn 89, Issue 5, 2015, Pages 2520-2529

  Garner, Omai B ^a   Yun, Tatyana ^b   Pernet, Olivier ^a   Aguilar, Hector C ^c   Park, Arnold ^a   Bowden, Thomas A ^d   Freiberg, Alexander N ^b   Lee, Benhur ^a,e   Baum, Linda G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 1; GLYCAN; GLYCOPROTEIN; LGALS1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPOSURE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIFE CYCLE; NIPAH VIRUS; NIPAH VIRUS INFECTION; NONHUMAN; SYNCYTIUM; VERO CELL LINE; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS RECOMBINANT; WILD TYPE; CELL CULTURE; GIANT CELL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

HUMAN HERPESVIRUS 1; NIPAH VIRUS; PARAMYXOVIRIDAE;

CELLS, CULTURED; ENDOTHELIAL CELLS; GALECTIN 1; GIANT CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; NIPAH VIRUS; VIRUS INTERNALIZATION;

EID: 84923008549     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02435-14     Document Type: Article

References (56)

1. Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, Neizgoda M, Ruppercht C, Bresee J, Breiman RF. 2004. Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis 10:2082-2087. http://dx.doi.org/10.3201/eid1012.040701.
2. Stone R. 2011. Epidemiology: breaking the chain in Bangladesh. Science 331:1128-1131. http://dx.doi.org/10.1126/science.331.6021.1128.
3. Nahar N, Mondal UK, Hossain MJ, Uddin Khan MS, Sultana R, Gurley ES, Luby SP. 2013. Piloting the promotion of bamboo skirt barriers to prevent Nipah virus transmission through date palm sap in Bangladesh. Glob Health Promot Int 28:378-386. http://dx.doi.org/10.1093/heapro/das020.
4. Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, Lee B. 2005. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436:401-405. http://dx.doi.org/10.1038/nature03838.
5. Negrete OA, Wolf MC, Aguilar HC, Enterlein S, Wang W, Muhlberger E, Su SV, Bertolotti-Ciarlet A, Flick R, Lee B. 2006. Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog 2:e7. http://dx.doi.org/10.1371/journal.ppat.0020007.
6. Aguilar HC, Iorio RM. 2012. Henipavirus membrane fusion and viral entry. Curr Top Microbiol Immunol 359:79-94. http://dx.doi.org/10.1007/82_2012_200.
7. Maisner A, Neufeld J, Weingartl H. 2009. Organ-and endotheliotropism of Nipah virus infections in vivo and in vitro. Thromb Haemost 102:1014-1023. http://dx.doi.org/10.1160/TH09-05-0310.
8. Behling-Kelly E, Czuprynski CJ. 2007. Endothelial cells as active participants in veterinary infections and inflammatory disorders. Anim Health Res Rev 8:47-58. http://dx.doi.org/10.1017/S1466252307001296.
9. Wahl-Jensen VM, Afanasieva TA, Seebach J, Stroher U, Feldmann H, Schnittler HJ. 2005. Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol 79:10442-10450. http://dx.doi.org/10.1128/JVI.79.16.10442-10450.2005.
10. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J, Mayo KH, Poirier F, Griffioen AW. 2006. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA 103:15975-15980. http://dx.doi.org/10.1073/pnas.0603883103.
11. Garner OB, Aguilar HC, Fulcher JA, Levroney EL, Harrison R, Wright L, Robinson LR, Aspericueta V, Panico M, Haslam SM, Morris HR, Dell A, Lee B, Baum LG. 2010. Endothelial galectin-1 binds to specific glycans on Nipah virus fusion protein and inhibits maturation, mobility, and function to block syncytia formation. PLoS Pathog 6:e1000993. http://dx.doi.org/10.1371/journal.ppat.1000993.
12. Warke RV, Xhaja K, Martin KJ, Fournier MF, Shaw SK, Brizuela N, de Bosch N, Lapointe D, Ennis FA, Rothman AL, Bosch I. 2003. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol 77:11822-11832. http://dx.doi.org/10.1128/JVI.77.21.11822-11832.2003.
13. Imaizumi T, Yoshida H, Nishi N, Sashinami H, Nakamura T, Hirashima M, Ohyama C, Itoh K, Satoh K. 2007. Double-stranded RNA induces galectin-9 in vascular endothelial cells: involvement of TLR3, PI3K, and IRF3 pathway. Glycobiology 17:12C-15C. http://dx.doi.org/10.1093/glycob/cwm045.
14. Stowell SR, Arthur CM, McBride R, Berger O, Razi N, Heimburg-Molinaro J, Rodrigues LC, Gourdine JP, Noll AJ, von Gunten S, Smith DF, Knirel YA, Paulson JC, Cummings RD. 2014. Microbial glycan microarrays define key features of host-microbial interactions. Nat Chem Biol 10:470-476. http://dx.doi.org/10.1038/nchembio.1525.
15. Stowell SR, Arthur CM, Dias-Baruffi M, Rodrigues LC, Gourdine JP, Heimburg-Molinaro J, Ju T, Molinaro RJ, Rivera-Marrero C, Xia B, Smith DF, Cummings RD. 2010. Innate immune lectins kill bacteria expressing blood group antigen. Nat Med 16:295-301. http://dx.doi.org/10.1038/nm.2103.
16. Kohatsu L, Hsu DK, Jegalian AG, Liu FT, Baum LG. 2006. Galectin-3 induces death of Candida species expressing specific β-1,2-linked mannans. J Immunol 177:4718-4726. http://dx.doi.org/10.4049/jimmunol.177.7.4718.
17. Gupta SK, Masinick S, Garrett M, Hazlett LD. 1997. Pseudomonas aeruginosa lipopolysaccharide binds galectin-3 and other human corneal epithelial proteins. Infect Immun 65:2747-2753.
18. Moody TN, Ochieng J, Villalta F. 2000. Novel mechanism that Trypanosoma cruzi uses to adhere to the extracellular matrix mediated by human galectin-3. FEBS Lett 470:305-308. http://dx.doi.org/10.1016/S0014-5793(00)01347-8.
19. Okumura CY, Baum LG, Johnson PJ. 2008. Galectin-1 on cervical epithelial cells is a receptor for the sexually transmitted human parasite Trichomonas vaginalis. Cell Microbiol 10:2078-2090. http://dx.doi.org/10.1111/j.1462-5822.2008.01190.x.
20. Ouellet M, Mercier S, Pelletier I, Bounou S, Roy J, Hirabayashi J, Sato S, Tremblay MJ. 2005. Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells. J Immunol 174:4120-4126. http://dx.doi.org/10.4049/jimmunol.174.7.4120.
21. Mercier S, St-Pierre C, Pelletier I, Oullet M, Tremblay MJ, Sato S. 2008. Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption. Virology 371:121-129. http://dx.doi.org/10.1016/j.virol.2007.09.034.
22. St-Pierre C, Manya H, Oullet M, Clark GF, Endo T, Tremblay MJ, Sato S. 2011. Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4. J Virol 85: 11742-11751. http://dx.doi.org/10.1128/JVI.05351-11.
23. Bi S, Hong PW, Lee B, Baum LG. 2011. Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry. Proc Natl Acad Sci USA 108:10650-10655. http://dx.doi.org/10.1073/pnas.1017954108.
24. Levroney EL, Aguilar HC, Fulcher JA, Kohatsu L, Pace KE, Pang M, Gurney KB, Baum LG, Lee B. 2005. Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines. J Immunol 175:413-420. http://dx.doi.org/10.4049/jimmunol.175.1.413.
25. Pace KE, Lee C, Stewart PL, Baum LG. 1999. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol 163:3801-3811.
26. Perillo NL, Uittenbogaart CH, Nguyen JT, Baum LG. 1997. Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J Exp Med 185:1851-1858. http://dx.doi.org/10.1084/jem.185.10.1851.
27. Aguilar HC, Matreyek KA, Filone CM, Hashimi ST, Levroney EL, Negrete OA, Bertolotti-Ciarlet A, Choi DY, McHardy I, Fulcher JA, Su SV, Wolf MC, Kohatsu L, Baum LG, Lee B. 2006. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J Virol 80:4878-4889. http://dx.doi.org/10.1128/JVI.80.10.4878-4889.2006.
28. Yun T, Park A, Hill TE, Pernet O, Beaty SM, Juelich TL, Smith JK, Zhang L, Wang YE, Vigant F, Gao J, Wu P, Lee B, Freiberg AN. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection. J Virol 89:1242-1253. http://dx.doi.org/10.1128/JVI.02583-14.
29. Tamin A, Harcourt BH, Lo MK, Roth JA, Wolf MC, Lee B, Weingartl H, Audonnet JC, Bellini WJ, Rota PA. 2009. Development of a neutralization assay for Nipah virus using pseudotype particles. J Virol Methods 160:1-6. http://dx.doi.org/10.1016/j.jviromet.2009.02.025.
30. Stachowiak JC, Brodsky FM, Miller EA. 2013. A cost-benefit analysis of the physical mechanisms of membrane curvature. Nat Cell Biol 15:1019-10127. http://dx.doi.org/10.1038/ncb2832.
31. Elbein AD, Tropea JE, Mitchell M, Kaushal GP. 1990. Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase. I J Biol Chem 265:15599-155605.
32. Nguyen JT, Evans DP, Galvan M, Pae KE, Leitenberg D, Bui TN, Baum LG. 2001. CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans. J Immunol 167:5697-56707. http://dx.doi.org/10.4049/jimmunol.167.10.5697.
33. Wolf MC, Wang Y, Freiberg AN, Aguilar HC, Holbrook MR, Lee B. 2009. A catalytically and genetically optimized beta-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics. Virol J 6:119. http://dx.doi.org/10.1186/1743-422X-6-119.
34. Pernet O, Schneider BS, Beaty SM, LeBreton M, Yun TE, Park A, Zachariah TT, Bowden TA, Hitchens P, Ramirez CM, Daszak P, Mazet J, Freiberg AN, Wolfe ND, Lee B. 2014. Evidence for henipavirus spillover into human populations in Africa. Nat Commun 5:5342. http://dx.doi.org/10.1038/ncomms6342.
35. Liu FT, Yang RY, Hsu DK. 2012. Galectins in acute and chronic inflammation. Ann N Y Acad Sci 1253:80-91. http://dx.doi.org/10.1111/j.1749-6632.2011.06386.x.
36. Cerliani JP, Stowell SR, Mascanfroni ID, Arthur CM, Cummings RD, Rabinovich GA. 2011. Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity. J Clin Immunol 31:10-21. http://dx.doi.org/10.1007/s10875-010-9494-2.
37. Dam TK, Brewer CF. 2010. Lectins as pattern recognition molecules: the effects of epitope density in innate immunity. Glycobiology 20:270-279. http://dx.doi.org/10.1093/glycob/cwp186.
38. Sato S, St-Pierre C, Bhaumik P, Nieminen J. 2009. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev 230: 172-187. http://dx.doi.org/10.1111/j.1600-065X.2009.00790.x.
39. Yang ML, Chen YH, Wang SW, Huang YJ, Leu CH, Yeh NC, Chu CY, Lin CC, Shieh GS, Chen YL, Wang JR, Wang CH, Wu CL, Shiau AL. 2011. Galectin-1 binds to influenza virus and ameliorates influenza virus pathogenesis. J Virol 85:10010-10020. http://dx.doi.org/10.1128/JVI.00301-11.
40. Earl LA, Bi S, Baum LG. 2010. N-and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death. J Biol Chem 285:2232-2244. http://dx.doi.org/10.1074/jbc.M109.066191.
41. Croci DO, Cerliani JP, Pinto NA, Morosi LG, Rabinovich GA. 2014. Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment. Glycobiology 24:1283-1290. http://dx.doi.org/10.1093/glycob/cwu083.
42. Xu K, Chan YP, Rajashankar KR, Khetawat D, Yan L, Kolev MV, Broder CC, Nikolov DB. 2012. New insights into the Hendra virus attachment and entry process from structures of the virus G glycoprotein and its complex with Ephrin-B2. PLoS One 7:e48742. http://dx.doi.org/10.1371/journal.pone.0048742.
43. Kase T, Suzuki Y, Kawai T, Sakamoto T, Ohtani K, Eda S, Maeda A, Okuno T, Kurimura T, Wakamiya N. 1999.Humanmannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology 97:385-392. http://dx.doi.org/10.1046/j.1365-2567.1999.00781.x.
44. Nguyen DG, Hildreth JE. 2003. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur J Immunol 33:483-493. http://dx.doi.org/10.1002/immu.200310024.
45. Liu Y, Liu H, Kim BO, Gattone VH, Li J, Nath A, Blum J, He JJ. 2004. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol 78: 4120-4133. http://dx.doi.org/10.1128/JVI.78.8.4120-4133.2004.
46. Lai J, Bernhard OK, Turville SG, Harman AN, Wilkinson J, Cunningham AL. 2009. Oligomerization of the macrophage mannose receptor enhances gp120-mediated binding of HIV-1. J Biol Chem 284:11027-11038. http://dx.doi.org/10.1074/jbc.M809698200.
47. Upham JP, Pickett D, Irimura T, Anders EM, Reading PC. 2010. Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry. J Virol 84:3730-3737. http://dx.doi.org/10.1128/JVI.02148-09.
48. Darrow AL, Shohet RV, Maresh JG. 2011. Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3. Physiol Genomics 20:1144-1152. http://dx.doi.org/10.1152/physiolgenomics.00035.2011.
49. Bi S, Earl LA, Jacobs L, Baum LG. 2008. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways. J Biol Chem 283:12248-12258. http://dx.doi.org/10.1074/jbc.M800523200.
50. Stillman BN, Hsu DK, Pang M, Brewer CF, Johnson P, Liu FT, Baum LG. 2006. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol 176:778-789. http://dx.doi.org/10.4049/jimmunol.176.2.778.
51. He J, Baum LG. 2004. Presentation of galectin-1 by extracellular matrix triggers T cell death. J Biol Chem 279:4705-4712. http://dx.doi.org/10.1074/jbc.M311183200.
52. Arnold K, Bordoli L, Kopp J, Schwede T. 2006. The SWISS-MODEL workspace: a web-based environment for protein structure homology modeling. Bioinformatics 22:195-201. http://dx.doi.org/10.1093/bioinformatics/bti770.
53. Yin HS, Wen X, Paterson RG, Lamb RA, Jardetzky TS. 2006. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 439:38-44. http://dx.doi.org/10.1038/nature04322.
54. Crispin M, Yu X, Bowden TA. 2013. Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy. Proc Natl Acad Sci USA 110:E3544-E3546. http://dx.doi.org/10.1073/pnas.1310657110.
55. Crispin M, Bowden TA, Coles CH, Harlos K, Aricescu AR, Harvey DJ, Stuart DI, Jones EY. 2009. Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions. J Mol Biol 387:1061-1066. http://dx.doi.org/10.1016/j.jmb.2009.02.033.
56. Lopez-Lucendo MF, Solis D, Andre S, Hirabayashi J, Kasai K, Kaltner H, Gabius HJ, Romero A. 2004. Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. J Mol Biol 343:957-970. http://dx.doi.org/10.1016/j.jmb.2004.08.078.